Sanford C. Bernstein Raises CVS Health (NYSE:CVS) Price Target to $106.00

CVS Health (NYSE:CVS) had its target price boosted by analysts at Sanford C. Bernstein from $94.00 to $106.00 in a report issued on Tuesday,MarketScreener reports. The brokerage currently has an “outperform” rating on the pharmacy operator’s stock. Sanford C. Bernstein’s price target would indicate a potential upside of 14.58% from the company’s previous close.

Other equities analysts have also issued research reports about the stock. Wells Fargo & Company boosted their price objective on shares of CVS Health from $102.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday. Bank of America dropped their target price on CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a research report on Tuesday, January 27th. Royal Bank Of Canada boosted their price target on CVS Health from $93.00 to $107.00 and gave the stock an “outperform” rating in a research note on Thursday. Piper Sandler lowered their price objective on CVS Health from $101.00 to $99.00 and set an “overweight” rating for the company in a research note on Tuesday, March 31st. Finally, Wall Street Zen upgraded CVS Health from a “hold” rating to a “buy” rating in a report on Saturday. Twenty-two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $97.00.

CVS Health Stock Up 0.3%

NYSE CVS traded up $0.29 on Tuesday, reaching $92.51. The company had a trading volume of 917,495 shares, compared to its average volume of 8,509,286. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health has a 1 year low of $58.35 and a 1 year high of $92.77. The firm has a 50-day moving average of $77.43 and a 200-day moving average of $78.15. The firm has a market capitalization of $118.04 billion, a PE ratio of 40.80, a P/E/G ratio of 0.88 and a beta of 0.60.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.21 by $0.36. The company had revenue of $100.43 billion for the quarter, compared to analyst estimates of $94.99 billion. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The business’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the firm posted $2.25 earnings per share. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, equities research analysts anticipate that CVS Health will post 7.48 EPS for the current fiscal year.

Insider Activity at CVS Health

In other news, EVP Tilak Mandadi sold 69,551 shares of the company’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the completion of the transaction, the executive vice president owned 10,133 shares in the company, valued at approximately $907,714.14. This represents a 87.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.85% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. National Pension Service lifted its stake in shares of CVS Health by 3.1% in the 3rd quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock worth $301,532,000 after acquiring an additional 119,189 shares during the period. Kingsview Wealth Management LLC increased its stake in shares of CVS Health by 316.2% during the third quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator’s stock valued at $7,873,000 after acquiring an additional 79,340 shares during the period. AE Wealth Management LLC raised its holdings in CVS Health by 6.2% during the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock worth $19,391,000 after purchasing an additional 14,983 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in CVS Health by 11.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock worth $16,971,000 after purchasing an additional 22,653 shares during the period. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in CVS Health by 186.6% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator’s stock valued at $30,568,000 after purchasing an additional 258,050 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health News Roundup

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: TD Cowen raised its price target on CVS Health to $110 from $105 and reiterated a buy rating, reinforcing bullish sentiment after the company’s earnings beat and higher guidance. TD Cowen adjusts price target on CVS Health to 110 from 105
• Positive Sentiment: Recent coverage says CVS looks undervalued, highlighting stronger Q1 revenue, higher EPS, and improving margins and medical benefit trends as signs that the turnaround is gaining traction. CVS Health: Still Cheap And Signs Of Improvement
• Positive Sentiment: CVS also continues to get a lift from broader bullish market commentary, including mentions on CNBC’s “Final Trades” and technical reports saying the stock has broken out after a long consolidation. Nvidia, CVS Health, Vertiv and an energy stock on CNBC’s Final Trades
• Neutral Sentiment: CVS EVP Tilak Mandadi disclosed a sale of 69,551 shares at an average price of $89.58. Insider selling can get attention, but this appears more like a portfolio reduction than a clear fundamental warning. SEC Form 4 filing
• Neutral Sentiment: CVS is also expanding community-care initiatives, including a MinuteClinic partnership in Connecticut and health funding in Missouri, which supports its longer-term strategy but is not an immediate earnings catalyst. CVS Health Expands Community Care Push As Valuation Gap Draws Attention

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.